Daley Lab publications: (last updated on July 30, 2007)
Click Here for Latest Publication List
(PubMed database at the National Library of Medicine)
Wu X, Lensch MW, Wylie-Sears J, Daley GQ, Bischoff J. Progenitors Cells Isolated from Human Umbilical Cord Blood. Stem Cells. 2007 Jul 19. (go to abstract)
Cortes J, Jabbour E, Daley GQ, O'brien S, Verstovsek S, Ferrajoli A, Koller C, Zhu Y, Statkevich P, Kantarjian H. Phase 1 study of lonafarnib (SCH 66336) and imatinib mesylate in patients with chronic myeloid leukemia who have failed prior single-agent therapy with imatinib. Cancer. 2007 Jul 10. (go to abstract)
Lensch MW, Daley GQ. Human embryonic stem cells flock together. Nat Biotechnol. 2007 Jul;25(7):748-750. Review. (go to abstract)
North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM, Weber GJ, Bowman TV, Jang IH, Grosser T, Fitzgerald GA, Daley GQ, Orkin SH, Zon LI. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature. 2007 Jun 21;447(7147):1007-11. (go to abstract)
Raz T, Nardi V, Azam M, Cortes J, Daley GQ. Farnesyl transferase inhibitor resistance probed by target mutagenesis. Blood. 2007 May 29. (go to abstract)
McKinney-Freeman SL, Daley GQ. Towards hematopoietic reconstitution from embryonic stem cells: a sanguine future. Curr Opin Hematol. 2007 Jul;14(4):343-7. Review. (go to abstract)
West JA, Park IH, Daley GQ, Geijsen N. In vitro generation of germ cells from murine embryonic stem cells. Nat Protoc. 2006;1(4):2026-36. (go to abstract)
Daley GQ. Gametes from embryonic stem cells: a cup half empty or half full? Science. 2007 Apr 20;316(5823):409-10. Review. (go to abstract)
Chen Z, Naveiras O, Balduini A, Mammoto A, Conti MA, Adelstein RS, Ingber D, Daley GQ, Shivdasani RA. The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway. Blood. 2007 Jul 1;110(1):171-9. (go to abstract)
Lengerke C, Kim K, Lerou P, Daley GQ. Differentiation potential of histocompatible parthenogenetic embryonic stem cells. Ann N Y Acad Sci. 2007 Jun;1106:209-18. (go to abstract)
Lengerke C, McKinney-Freeman S, Naveiras O, Yates F, Wang Y, Bansal D, Daley GQ. The cdx-hox pathway in hematopoietic stem cell formation from embryonic stem cells. Ann N Y Acad Sci. 2007 Jun;1106:197-208. (go to abstract)
Daley
GQ, Ahrlund Richter L, Auerbach JM, Benvenisty N, Charo RA, Chen G, Deng HK,
Goldstein LS, Hudson KL, Hyun I, Junn SC, Love J, Lee EH, McLaren A, Mummery
CL, Nakatsuji N, Racowsky C, Rooke H, Rossant J, Scholer HR, Solbakk JH, Taylor
P, Trounson AO, Weissman IL, Wilmut I, Yu J, Zoloth L.
Ethics. The ISSCR guidelines for human embryonic stem cell research. Science.
2007 Feb 2;315(5812):603-4.
(go
to abstract)
Kim
K, Lerou P, Yabuuchi A, Lengerke C, Ng K, West J, Kirby A, Daly MJ, Daley
GQ.
Histocompatible Embryonic
Stem Cells by Parthenogenesis.
Science. 2006 Dec 14;Jan 26;315(5811):482-6. (go
to abstract)
Zaehres
H, Daley GQ.
Transgene expression and RNA interference in embryonic stem cells.
Methods Enzymol. 2006;420:49-64. Review.
(go
to abstract)
Geijsen
N, Daley GQ.
Male germ cells.
Methods Enzymol. 2006;418:307-14. Review.
(go
to abstract)
Bansal
D, Scholl C, Frohling S, McDowell E, Lee BH, Dohner K, Ernst P, Davidson AJ,
Daley GQ, Zon LI, Gilliland DG, Huntly BJ.
Cdx4 dysregulates Hox gene expression and generates acute myeloid leukemia
alone and in cooperation with Meis1a in a murine model.
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16924-9. (go
to abstract)
Yates
F, Daley GQ.
Progress and prospects: gene transfer into embryonic stem cells.
Gene Ther. 2006 Oct;13(20):1431-9. Review.
(go
to abstract)
Azam
M, Nardi V, Shakespeare WC, Metcalf CA 3rd, Bohacek RS, Wang Y, Sundaramoorthi
R, Sliz P, Veach DR, Bornmann WG, Clarkson B, Dalgarno DC, Sawyer TK, Daley
GQ.
Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase
dynamics in drug resistance.
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9244-9. (go
to abstract)
Azam
M, Daley GQ.
Anticipating clinical resistance to target-directed agents: the BCR-ABL paradigm.
Mol Diagn Ther. 2006;10(2):67-76. Review.
(go
to abstract)
Naveiras
O, Daley GQ.
Stem cells and their niche: a matter of fate.
Cell Mol Life Sci. 2006 Apr;63(7-8):760-6. Review.
(go
to abstract)
Willey
S, Ayuso-Sacido A, Zhang H, Fraser ST, Sahr KE, Adlam MJ, Kyba M, Daley GQ,
Keller G, Baron MH.
Acceleration of mesoderm development and expansion of hematopoietic progenitors
in differentiating ES cells by the mouse Mix-like homeodomain transcription
factor.
Blood. 2006 Apr 15;107(8):3122-30. (go
to abstract)
Wang
Y, Yates F, Naveiras O, Ernst P, Daley GQ.
Embryonic stem cell-derived hematopoietic stem cells.
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19081-19086.
(go
to abstract)
Gunawardane
RN, Sgroi DC, Wrobel CN, Koh E, Daley GQ, Brugge JS.
Novel role for PDEF in epithelial cell migration and
invasion.
Cancer Res. 2005 Dec 15;65(24):11572-80. (go
to abstract)
Lensch
MW, Daley GQ.
Scientific and clinical opportunities for modeling blood disorders with embryonic
stem cells.
Blood. 2005 Dec 6; [Epub ahead of print]. Review.
(go
to abstract)
Lerou
PH and Daley GQ.
Therapeutic potential of embryonic stem cells.
Blood Rev. 2005 Nov;19(6):321-331. Review
(go
to abstract)
Lengerke
C and Daley GQ.
Patterning definitive hematopoietic stem cells from embryonic stem cells.
Exp Hematol. 2005 Sep;33(9):971-979. Review
(go
to abstract)
Daley
GQ.
Customized human embryonic stem cells.
Nat Biotechnol. 2005 Jul;23(7):826-8. (go
to abstract)
Daley
GQ, Sandel MJ, Moreno JD.
Stem cell research: science, ethics and policy.
Med Ethics (Burlingt, Mass). 2005 Winter;12(1):5. (go
to abstract)
Zaehres
H, Lensch MW, Daheron L, Stewart SA, Itskovitz-Eldor J, Daley GQ.
High-efficiency RNA interference in human embryonic stem cells.
Stem Cells. 2005 Mar;23(3):299-305. (go
to abstract)
Barnes
K, McIntosh E, Whetton AD, Daley GQ, Bentley J, Baldwin SA.
Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced
abnormalities in glucose transport regulation.
Oncogene. 2005 May 5;24(20):3257-67. (go
to abstract)
Kubo
A, Chen V, Kennedy M, Zahradka E, Daley GQ, Keller G.
The homeobox gene HEX regulates proliferation and differentiation of hemangioblasts
and endothelial cells during ES cell differentiation.
Blood. 2005 Jun 15;105(12):4590-7. Epub 2005 Feb 22. (go
to abstract)
Melton
DA, Daley GQ, Jennings CG.
Altered nuclear transfer in stem-cell research - a flawed proposal.
N Engl J Med. 2004 Dec 30;351(27):2791-2. (go
to abstract)
West
JA, Daley GQ.
In vitro gametogenesis from embryonic stem cells.
Curr Opin Cell Biol. 2004 Dec;16(6):688-92. Review
(go
to abstract)
Daley
GQ.
Chronic myeloid leukemia.
Cell. 2004 Oct 29;119(3):314-6. Review
(go
to abstract)
Ting
DT, Kyba M, Daley GQ.
Inducible transgene expression in mouse stem cells.
Methods Mol Med. 2004;105:23-46. Review
(go
to abstract)
Woolf
PJ, Prudhomme W, Daheron L, Daley GQ, Lauffenburger DA.
Bayesian analysis of signaling networks governing embryonic stem cell fate
decisions.
Bioinformatics. 2004 Oct 12 [Epub ahead of print] (go
to abstract)
Daheron
L, Opitz SL, Zaehres H, Lensch WM, Andrews PW, Itskovitz-Eldor J, Daley GQ.
LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem
cells.
Stem Cells. 2004;22(5):770-8. (go
to abstract)
Daley
GQ.
Missed opportunities in embryonic stem-cell research.
N Engl J Med. 2004 Aug 12;351(7):627-8. Epub 2004 Aug 09. Review
(go
to abstract)
Daley
GQ.
Alchemy in the liver: fact or fusion?
Nat Med. 2004 Jul;10(7):671-2.
Review (go
to abstract)
Hochedlinger
K, Rideout WM, Kyba M, Daley GQ, Blelloch R, Jaenisch R.
Nuclear transplantation, embryonic stem cells and the potential for cell therapy.
Hematol J. 2004;5 Suppl 3:S114-7. Review
(go
to abstract)
Daley
GQ.
Introducing a "How-to" Guide to Embryonic Stem Cell Manipulation.
Stem Cells. 2004;22(3):242. Review (go
to abstract)
Lensch
MW, Daley GQ.
Origins of mammalian hematopoiesis: in vivo paradigms and in vitro models.
Curr Top Dev Biol. 2004;60:127-96. Review.
(go
to abstract)
Martin
SS, Ridgeway AG, Pinkas J, Lu Y, Reginato MJ, Koh EY, Michelman M, Daley GQ,
Brugge JS, Leder P.
A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer
of metastasis, but not primary tumor growth.
Oncogene. 2004 Jun 3;23(26):4641-5. (go
to abstract)
Snyder
EY, Daley GQ, Goodell M.
Taking stock and planning for the next decade: realistic prospects for stem
cell therapies for the nervous system.
J Neurosci Res. 2004 Apr 15;76(2):157-68. Review.
(go
to abstract)
Prudhomme
W, Daley GQ, Zandstra P, Lauffenburger DA.
Multivariate proteomic analysis of murine embryonic stem cell self-renewal
versus differentiation signaling.
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2900-5. Epub 2004 Feb 20.
(go
to abstract)
West
JA, Daley GQ.
Human embryonic stem cells.
Bone Marrow Transplant. 2004 Jan;33(1):135. Review
(go
to abstract)
Kyba
M, Perlingeiro RC, Daley GQ.
Development of hematopoietic repopulating cells from embryonic stem cells.
Methods Enzymol. 2003;365:114-29. (go
to abstract)
Nardi
V, Azam M, Daley GQ.
Mechanisms and implications of imatinib resistance mutations in BCR-ABL.
Curr Opin Hematol. 2004 Jan;11(1):35-43. (go
to abstract)
Geijsen
N, Horoschak M, Kim K, Gribnau J, Eggan K, Daley GQ.
Derivation of embryonic germ cells and male gametes from embryonic stem cells.
Nature. 2004 Jan 8;427(6970):148-54. Epub 2003 Dec 10. (go
to abstract)
Koh
EY, Chen T, Daley GQ.
Genetic complementation of cytokine signaling identifies central role of kinases
in hematopoietic cell proliferation.
Oncogene. 2004 Feb 12;23(6):1214-20. (go
to abstract)
Daley
GQ, Goodell MA, Snyder EY.
Realistic prospects for stem cell therapeutics.
Hematology (Am Soc Hematol Educ Program). 2003;:398-418. (go
to abstract)
Azam
M, Raz T, Nardi V, Opitz SL, Daley GQ.
A screen to identify drug resistant variants to target-directed anti-cancer
agents.
Biol Proced Online. 2003;5:204-210. Epub 2003 Oct 24. (go
to abstract)
Kyba
M, Daley GQ.
Hematopoiesis from embryonic stem cells: lessons from and for ontogeny.
Exp Hematol. 2003 Nov;31(11):994-1006. Review.
(go
to abstract)
Larson
RA, Daley GQ, Schiffer CA, Porcu P, Pui CH, Marie JP, Steelman LS, Bertrand
FE, McCubrey JA.
Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania,
December 2002.
Leukemia. 2003 Dec;17(12):2358-82. (go
to abstract)
Davidson
AJ, Ernst P, Wang Y, Dekens MP, Kingsley PD, Palis J, Korsmeyer SJ, Daley
GQ, Zon LI.
cdx4 mutants fail to specify blood progenitors and can be rescued by multiple
hox genes.
Nature. 2003 Sep 18;425(6955):300-6. (go
to abstract)
Kyba
M, Perlingeiro RC, Hoover RR, Lu CW, Pierce J, Daley GQ.
Enhanced hematopoietic differentiation of embryonic stem cells conditionally
expressing Stat5.
Proc Natl Acad Sci U S A. 2003 Sep 30;100 Suppl 1:11904-10. Epub 2003
Aug 20. (go
to abstract)
Daley
GQ.
Cloning and stem cells--handicapping the political and scientific debates.
N Engl J Med. 2003 Jul 17;349(3):211-2. (go
to abstract)
Daley
GQ.
ES cells prove egg-straordinary.
Nat Biotechnol. 2003 Jul;21(7):760-1. (go
to abstract)
Daley
GQ.
From embryos to embryoid bodies: generating blood from embryonic stem cells.
Ann N Y Acad Sci. 2003 May;996:122-31. Review.
(go
to abstract)
Daley
GQ.
Towards combination target-directed chemotherapy for chronic myeloid leukemia:
role of farnesyl transferase inhibitors.
Semin Hematol. 2003 Apr;40(2 Suppl 2):11-4. Review.
(go
to abstract)
Perlingeiro
RC, Kyba M, Bodie S, Daley GQ.
A role for thrombopoietin in hemangioblast development.
Stem Cells. 2003;21(3):272-80. (go
to abstract)
Daley
GQ.
Gleevec resistance: lessons for target-directed drug development.
Cell Cycle. 2003 May-Jun;2(3):190-1. Review.
(go
to abstract)
Daley
GQ.
Dodging the magic bullet: understanding imatinib resistance.
Cancer Biol Ther. 2003 Jan-Feb;2(1):109-10. (go
to abstract)
Azam
M, Latek RR, Daley GQ.
Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis
of BCR-ABL.
Cell. 2003 Mar 21;112(6):831-43. (go
to abstract)
Koh
EY, Chen T, Daley GQ.
Novel retroviral vectors to facilitate expression screens in mammalian cells.
Nucleic Acids Res. 2002 Dec 15;30(24):e142. (go
to abstract)
Daley
GQ.
Prospects for stem cell therapeutics: myths and medicines.
Curr Opin Genet Dev. 2002 Oct;12(5):607-13. Review.
(go
to abstract)
Hoover
RR, Mahon FX, Melo JV, Daley GQ.
Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336.
Blood. 2002 Aug 1;100(3):1068-71. (go
to abstract)
Kyba
M, Perlingeiro RC, Daley GQ.
HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic
stem cell and yolk sac hematopoietic progenitors.
Cell. 2002 Apr 5;109(1):29-37. (go
to abstract)
Rideout
WM 3rd, Hochedlinger K, Kyba M, Daley GQ, Jaenisch R.
Correction of a genetic defect by nuclear transplantation and combined cell
and gene therapy.
Cell. 2002 Apr 5;109(1):17-27. (go
to abstract)
Dang
SM, Kyba M, Perlingeiro R, Daley GQ, Zandstra PW.
Efficiency of embryoid body formation and hematopoietic development from embryonic
stem cells in different culture systems.
Biotechnol Bioeng. 2002 May 20;78(4):442-53. (go
to abstract)
Shvarts
A, Brummelkamp TR, Scheeren F, Koh E, Daley GQ, Spits H, Bernards R.
A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative
p19(ARF)-p53 signaling.
Genes Dev. 2002 Mar 15;16(6):681-6. (go
to abstract)
Peeper
DS, Shvarts A, Brummelkamp T, Douma S, Koh EY, Daley GQ, Bernards R.
A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced
senescence.
Nat Cell Biol. 2002 Feb;4(2):148-53. (go
to abstract)
Jena
N, Deng M, Sicinska E, Sicinski P, Daley GQ.
Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic
cells.
Cancer Res. 2002 Jan 15;62(2):535-41. (go
to abstract)
Topol
EJ, McCarthy J, Gabriel S, Moliterno DJ, Rogers WJ, Newby LK, Freedman M,
Metivier J, Cannata R, O'Donnell CJ, Kottke-Marchant K, Murugesan G, Plow
EF, Stenina O, Daley GQ.
Single nucleotide polymorphisms in multiple novel thrombospondin genes may
be associated with familial premature myocardial infarction.
Circulation. 2001 Nov 27;104(22):2641-4. (go
to abstract)
Perlingeiro
RC, Kyba M, Daley GQ.
Clonal analysis of differentiating embryonic stem cells reveals a hematopoietic
progenitor with primitive erythroid and adult lymphoid-myeloid potential.
Development. 2001 Nov;128(22):4597-604. (go
to abstract)
Hoover
RR, Gerlach MJ, Koh EY, Daley GQ.
Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed
hematopoietic cells.
Oncogene. 2001 Sep 13;20(41):5826-35. (go
to abstract)
Daley
GQ, Cargill M.
The heart SNPs a beat: polymorphisms in candidate genes for cardiovascular
disease.
Trends Cardiovasc Med. 2001 Feb;11(2):60-6. Review.
(go
to abstract)
Peters
DG, Klucher KM, Perlingeiro RC, Dessain SK, Koh EY, Daley GQ.
Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed
hematopoietic cell line that induces leukemia in mice.
Oncogene. 2001 May 10;20(21):2636-46. (go
to abstract)
Deng
M, Daley GQ.
Expression of interferon consensus sequence binding protein induces potent
immunity against BCR/ABL-induced leukemia.
Blood. 2001 Jun 1;97(11):3491-7. (go
to abstract)
Cargill
M, Daley GQ.
Mining for SNPs: putting the common variants-common disease hypothesis to
the test.
Pharmacogenomics. 2000 Feb;1(1):27-37. Review.
(go
to abstract)
Peters
DG, Hoover RR, Gerlach MJ, Koh EY, Zhang H, Choe K, Kirschmeier P, Bishop
WR, Daley GQ.
Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced
murine leukemia and primary cells from patients with chronic myeloid leukemia.
Blood. 2001 Mar 1;97(5):1404-12. (go
to abstract)
Reichert
A, Heisterkamp N, Daley GQ, Groffen J.
Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic
mice with the farnesyl transferase inhibitor SCH66336.
Blood. 2001 Mar 1;97(5):1399-403. (go
to abstract)
Jacobs
JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof PM, van
Welsem T, van de Vijver MJ, Koh EY, Daley GQ, van Lohuizen M.
Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF))
and is amplified in a subset of human breast cancers.
Nat Genet. 2000 Nov;26(3):291-9. (go
to abstract)
Berns
K, Hijmans EM, Koh E, Daley GQ, Bernards R.
A genetic screen to identify genes that rescue the slow growth phenotype of
c-myc null fibroblasts.
Oncogene. 2000 Jul 6;19(29):3330-4. (go
to abstract)
Zandstra
PW, Le HV, Daley GQ, Griffith LG, Lauffenburger DA.
Leukemia inhibitory factor (LIF) concentration modulates embryonic stem cell
self-renewal and differentiation independently of proliferation.
Biotechnol Bioeng. 2000 Sep 20;69(6):607-17. (go
to abstract)
Salgia
R, Quackenbush E, Lin J, Souchkova N, Sattler M, Ewaniuk DS, Klucher KM, Daley
GQ, Kraeft SK, Sackstein R, Alyea EP, von Andrian UH, Chen LB, Gutierrez-Ramos
JC, Pendergast AM, Griffin JD.
The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha.
Blood. 1999 Dec 15;94(12):4233-46. (go
to abstract)
Ghaffari
S, Wu H, Gerlach M, Han Y, Lodish HF, Daley GQ.
BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development
in erythropoietin receptor-deficient progenitor cells.
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13186-90.
(go
to abstract)
Ghaffari
S, Daley GQ, Lodish HF.
Growth factor independence and BCR/ABL transformation: promise and pitfalls
of murine model systems and assays.
Leukemia. 1999 Aug;13(8):1200-6. Review.
(go
to abstract)
Cargill
M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim
EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington
J, Lipshutz R, Daley GQ, Lander ES.
Characterization of single-nucleotide polymorphisms in coding regions of human
genes.
Nat Genet. 1999 Jul;22(3):231-8. (go
to abstract)
Li
S, Ilaria RL Jr, Million RP, Daley GQ, Van Etten RA.
The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic
myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic
activity.
J Exp Med. 1999 May 3;189(9):1399-412. (go
to abstract)
Klucher
KM, Lopez DV, Daley GQ.
Secondary mutation maintains the transformed state in BaF3 cells with inducible
BCR/ABL expression.
Blood. 1998 May 15;91(10):3927-34. (go
to abstract)
Socolovsky
M, Lodish HF, Daley GQ.
Control of hematopoietic differentiation: lack of specificity in signaling
by cytokine receptors.
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6573-5. (go
to abstract)
Murray
PJ, Young RA, Daley GQ.
Hematopoietic remodeling in interferon-gamma-deficient mice infected with
mycobacteria.
Blood. 1998 Apr 15;91(8):2914-24. (go
to abstract)
Klucher
KM, Gerlach MJ, Daley GQ.
A novel method to isolate cells with conditional gene expression using fluorescence
activated cell sorting.
Nucleic Acids Res. 1997 Dec 1;25(23):4858-60. (go
to abstract)
Daley
GQ.
Rationalizing autotransplant strategies for chronic myeloid leukemia.
Leuk Lymphoma. 1996 May;21(5-6):353-8. Review.
(go
to abstract)
Daley
GQ.
Genetic events in CML: from translocation to transplantation.
Bone Marrow Transplant. 1994;14 Suppl 3:S5-9. Review.
(go
to abstract)
Daley
GQ, Goldman JM.
Autologous transplant for CML revisited.
Exp Hematol. 1993 Jun;21(6):734-7. Review.
(go
to abstract)
Daley
GQ.
Animal models of BCR/ABL-induced leukemias.
Leuk Lymphoma. 1993;11 Suppl 1:57-60. Review.
(go
to abstract)
Daley
GQ, Van Etten RA, Jackson PK, Bernards A, Baltimore D.
Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell
line.
Mol Cell Biol. 1992 Apr;12(4):1864-71. (go
to abstract)
Daley
GQ, Van Etten RA, Baltimore D.
Blast crisis in a murine model of chronic myelogenous leukemia.
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11335-8.
(go
to abstract)
Scott
ML, Van Etten RA, Daley GQ, Baltimore D.
v-abl causes hematopoietic disease distinct from that caused by bcr-abl.
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6506-10. (go
to abstract)
Varticovski
L, Daley GQ, Jackson P, Baltimore D, Cantley LC.
Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene
variants.
Mol Cell Biol. 1991 Feb;11(2):1107-13. (go
to abstract)
Daley
GQ, Ben-Neriah Y.
Implicating the bcr/abl gene in the pathogenesis of Philadelphia chromosome-positive
human leukemia.
Adv Cancer Res. 1991;57:151-84. Review.
(go
to abstract)
Daley
GQ, Van Etten RA, Baltimore D.
Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene
of the Philadelphia chromosome.
Science. 1990 Feb 16;247(4944):824-30. (go
to abstract)
Daley
GQ, Baltimore D.
Transformation of an interleukin 3-dependent hematopoietic cell line by the
chronic myelogenous leukemia-specific P210bcr/abl protein.
Proc Natl Acad Sci U S A. 1988 Dec;85(23):9312-6. (go
to abstract)
Daley
GQ, McLaughlin J, Witte ON, Baltimore D.
The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3
fibroblasts.
Science. 1987 Jul 31;237(4814):532-5. (go
to abstract)
Mes-Masson
AM, McLaughlin J, Daley GQ, Paskind M, Witte ON.
Overlapping cDNA clones define the complete coding region for the P210c-abl
gene product associated with chronic myelogenous leukemia cells containing
the Philadelphia chromosome.
Proc Natl Acad Sci U S A. 1986 Dec;83(24):9768-72. (go
to abstract)
Ben-Neriah
Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D.
The chronic myelogenous leukemia-specific P210 protein is the product of the
bcr/abl hybrid gene.
Science. 1986 Jul 11;233(4760):212-4. (go
to abstract)
Ben-Neriah
Y, Bernards A, Paskind M, Daley GQ, Baltimore D.
Alternative 5' exons in c-abl mRNA.
Cell. 1986 Feb 28;44(4):577-86. (go
to abstract)
Foster
DA, Levy JB, Daley GQ, Simon MC, Hanafusa H.
Isolation of chicken cellular DNA sequences with homology to the region of
viral oncogenes that encodes the tyrosine kinase domain.
Mol Cell Biol. 1986 Jan;6(1):325-31. (go
to abstract)
Return
to Daley Lab homepage 